The Bill and Melinda Gates Foundation says it will spend US$120 million to boost access to generic versions of drugmaker Merck’s antiviral COVID-19 pill for lower income countries, if the drug gets approved by regulators.
Source: ctv business
Gates Foundation to spend US0M on access for COVID-19 pill

